CP55940 (CP)
Created by Pfizer in 1974.
Agonist at both CB1 and CB2 receptors
CB1 Ki = 0.58nM
CB2 Ki = 0.68nM
Antagonist at GPR55 (CB3)
CP55940 is 45 times more potent than Δ9-THC, and is fully antagonized by rimonabant (SR141716A).
Showing posts with label CP 55940. Show all posts
Showing posts with label CP 55940. Show all posts
Friday, February 18, 2011
CP 55940
CP55940 (CP)
Created by Pfizer in 1974.
Agonist at both CB1 and CB2 receptors
CB1 Ki = 0.58nM
CB2 Ki = 0.68nM
Antagonist at GPR55 (CB3)
CP55940 is 45 times more potent than Δ9-THC, and is fully antagonized by rimonabant (SR141716A).
Subscribe to:
Posts (Atom)